• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺静脉外驱动灶标测和消融治疗肥胖患者持续性心房颤动。

Extra-pulmonary vein driver mapping and ablation for persistent atrial fibrillation in obese patients.

机构信息

Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, No.241 West Huaihai Road, Xuhui District, Shanghai 200030, China.

出版信息

Europace. 2021 May 21;23(5):701-709. doi: 10.1093/europace/euaa314.

DOI:10.1093/europace/euaa314
PMID:33554255
Abstract

AIMS

The aim of this study was to determine whether driver ablation effectively treats persistent atrial fibrillation (AF) in obese patients.

METHODS AND RESULTS

We randomly assigned 124 persistent AF obese patients to two groups, one undergoing conventional ablation (n = 62) and the other undergoing driver ablation (n = 62). Sixty-two non-obese patients with persistent AF undergoing driver ablation served as matched controls. Bipolar electrogram dispersion was analysed for driver mapping. Epicardial adipose tissue (EAT) volume was measured using cardiac computed tomography. Obese patients had a higher proportion of driver regions in the posterior wall (56.5% vs. 32.3%, P = 0.007). Driver complexity, measured as the average number and area of driver regions, was higher in the obese group than in the non-obese group (3.5 ± 1.0 vs. 2.9 ± 0.9, P < 0.001; 15.5% ± 4.2% vs. 9.8 ± 2.6%, P < 0.001, respectively). Left atrial EAT volume correlated better with the proportion of area of driver regions than did body mass index (BMI) and total EAT (BMI: r2 = 0.250, P < 0.001; total EAT: r2 = 0.379, P < 0.001; and left atrial EAT: r2 = 0.439, P < 0.001). The rate of AF termination was significantly higher in the driver ablation group than in the conventional ablation group (82.9% vs. 22.8%, P < 0.001). During the follow-up period of 16.9 ± 6.5 months, patients in the driver ablation group had significantly better AF-free survival (91.91% vs. 79.0%, log rank test, P = 0.026) and AF/atrial tachycardia-free survival (83.9% vs. 64.5%, log rank test, P = 0.011) than did patients in the conventional ablation group.

CONCLUSION

Obesity is associated with increased driver complexity. Driver ablation improves long-term outcomes in obese patients with persistent AF.

摘要

目的

本研究旨在确定消融是否能有效治疗肥胖患者持续性心房颤动(房颤)。

方法和结果

我们将 124 例持续性肥胖房颤患者随机分为两组,一组进行常规消融(n=62),另一组进行驱动消融(n=62)。62 例非肥胖持续性房颤患者接受驱动消融作为匹配对照组。进行驱动标测分析双极电图离散度。使用心脏计算机断层扫描测量心外膜脂肪组织(EAT)体积。肥胖患者后壁驱动区域的比例较高(56.5%比 32.3%,P=0.007)。与非肥胖组相比,肥胖组的驱动复杂性更高,表现为驱动区域的平均数量和面积更高(3.5±1.0比 2.9±0.9,P<0.001;15.5%±4.2%比 9.8%±2.6%,P<0.001)。左心房 EAT 体积与驱动区域面积比例的相关性优于 BMI 和总 EAT(BMI:r2=0.250,P<0.001;总 EAT:r2=0.379,P<0.001;左心房 EAT:r2=0.439,P<0.001)。驱动消融组的房颤终止率明显高于常规消融组(82.9%比 22.8%,P<0.001)。在 16.9±6.5 个月的随访期间,驱动消融组患者的无房颤生存率(91.91%比 79.0%,对数秩检验,P=0.026)和无房颤/房性心动过速生存率(83.9%比 64.5%,对数秩检验,P=0.011)明显高于常规消融组。

结论

肥胖与驱动复杂性增加有关。驱动消融可改善肥胖持续性房颤患者的长期预后。

相似文献

1
Extra-pulmonary vein driver mapping and ablation for persistent atrial fibrillation in obese patients.肺静脉外驱动灶标测和消融治疗肥胖患者持续性心房颤动。
Europace. 2021 May 21;23(5):701-709. doi: 10.1093/europace/euaa314.
2
Electrogram dispersion-guided driver ablation adjunctive to high-quality pulmonary vein isolation in atrial fibrillation of varying durations.电描记图分散指导的驱动消融辅助不同持续时间心房颤动的高质量肺静脉隔离。
J Cardiovasc Electrophysiol. 2020 Jan;31(1):48-60. doi: 10.1111/jce.14268. Epub 2019 Nov 20.
3
Extra pulmonary vein driver mapping and ablation in paroxysmal atrial fibrillation by electrogram dispersion analysis.肺静脉外驱动标测和房颤时电信号离散度分析指导下的消融。
J Cardiovasc Electrophysiol. 2019 Feb;30(2):164-170. doi: 10.1111/jce.13784. Epub 2018 Nov 21.
4
Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients.超重和肥胖患者行肺静脉隔离术后心房颤动复发率增加。
J Cardiovasc Electrophysiol. 2018 Feb;29(2):239-245. doi: 10.1111/jce.13388. Epub 2017 Dec 14.
5
Quantification of epicardial adipose tissue in patients undergoing hybrid ablation for atrial fibrillation.量化行杂交消融术治疗心房颤动患者的心外膜脂肪组织。
Eur J Cardiothorac Surg. 2019 Jul 1;56(1):79-86. doi: 10.1093/ejcts/ezy472.
6
Periatrial epicardial adipose tissue thickness is an independent predictor of atrial fibrillation recurrence after cryoballoon-based pulmonary vein isolation.心房周围的心外膜脂肪组织厚度是基于冷冻球囊肺静脉隔离术后房颤复发的独立预测因素。
J Cardiovasc Comput Tomogr. 2015 Jul-Aug;9(4):295-302. doi: 10.1016/j.jcct.2015.03.011. Epub 2015 Apr 7.
7
Isolation of the posterior left atrium for patients with persistent atrial fibrillation: routine adenosine challenge for dormant posterior left atrial conduction improves long-term outcome.对持续性心房颤动患者行左心房后壁隔离术:对隐匿性左心房后壁传导行常规腺苷激发试验可改善长期预后。
Europace. 2017 Dec 1;19(12):1958-1966. doi: 10.1093/europace/euw231.
8
Epicardial adipose tissue volume is not an independent predictor of atrial fibrillation recurrence after catheter ablation.心外膜脂肪组织体积不是导管消融术后心房颤动复发的独立预测因子。
Rev Esp Cardiol (Engl Ed). 2023 Jul;76(7):539-547. doi: 10.1016/j.rec.2022.11.006. Epub 2022 Nov 25.
9
Dispersion-guided ablation in conjunction with circumferential pulmonary vein isolation is superior to stepwise ablation approach for persistent atrial fibrillation.在持续性心房颤动中,与环肺静脉隔离相结合的弥散引导消融优于逐步消融方法。
Int J Cardiol. 2019 Mar 1;278:97-103. doi: 10.1016/j.ijcard.2018.12.051. Epub 2018 Dec 19.
10
Efficacy of an Adjunctive Electrophysiological Test-Guided Left Atrial Posterior Wall Isolation in Persistent Atrial Fibrillation Without a Left Atrial Low-Voltage Area.辅助电生理测试指导的左心房后壁隔离术在无左心房低电压区域的持续性心房颤动中的疗效。
Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e008191. doi: 10.1161/CIRCEP.119.008191. Epub 2020 Jul 13.

引用本文的文献

1
Targeting the Substrate: Mechanism-Based Ablation Strategies for Persistent Atrial Fibrillation.靶向底物:持续性心房颤动基于机制的消融策略
J Clin Med. 2025 Jul 20;14(14):5147. doi: 10.3390/jcm14145147.
2
Ablation Strategies for Persistent Atrial Fibrillation: Beyond the Pulmonary Veins.持续性心房颤动的消融策略:超越肺静脉
J Clin Med. 2024 Aug 25;13(17):5031. doi: 10.3390/jcm13175031.
3
Body mass index and pulmonary vein isolation: real-world data on outcomes and quality of life.体重指数与肺静脉隔离:真实世界数据下的疗效与生活质量。
Europace. 2024 Jun 3;26(6). doi: 10.1093/europace/euae157.
4
Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options.肥胖对心房颤动发病机制和治疗选择的影响。
J Am Heart Assoc. 2024 Jan 2;13(1):e032277. doi: 10.1161/JAHA.123.032277. Epub 2023 Dec 29.
5
Progress in atrial fibrillation ablation during 25 years of Europace journal.《 Europace 杂志 25 年期间心房颤动消融的进展》。
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad244.
6
Identification and Verification of Biomarkers and Immune Infiltration in Obesity-Related Atrial Fibrillation.肥胖相关性心房颤动中生物标志物的鉴定与验证及免疫浸润
Biology (Basel). 2023 Jan 12;12(1):121. doi: 10.3390/biology12010121.